Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

665 ARTÍCULOS , VIENDO DEL 421 AL 435

A Long-term Study of NeuroAid (MLC601, MLC901) in Patients with Alzheimer's Disease; An Extension 8-year Follow-up Study

Pakdaman H, Amini Harandi A, Gharagozli K, Siavoshi F, Shirzadeh Barough S, Sharifipour E, Esfandani A, Ilkhani S, Tabatabaei FS, Sobhanian SA.

Curr Aging Sci. 2023;16(3):234-239. doi: 10.2174/1874609816666230224111759.

Therapeutic potential of natural molecules against Alzheimer's disease via SIRT1 modulation

Zhang M, Tang Z.

Biomed Pharmacother. 2023 May;161:114474. doi: 10.1016/j.biopha.2023.114474. Epub 2023 Mar 4.

Psychometric properties of the Alzheimer's Disease Cooperative Study - Activities of Daily Living for Mild Cognitive Impairment (ADCS-MCI-ADL) scale: a post hoc analysis of the ADCS ADC-008 trial

Potashman M, Pang M, Tahir M, Shahraz S, Dichter S, Perneczky R, Nolte S.

BMC Geriatr. 2023 Mar 6;23(1):124. doi: 10.1186/s12877-022-03527-0.

Receptor for Advanced Glycation End Products: Dementia and Cognitive Impairment

Singh A, Ansari VA, Mahmood T, Ahsan F, Wasim R, Shariq M, Parveen S, Maheshwari S.

Drug Res (Stuttg). 2023 Jun;73(5):247-250. doi: 10.1055/a-2015-8041. Epub 2023 Mar 8.

Kaempferol as a therapeutic agent in Alzheimer's disease: Evidence from preclinical studies

Dong X, Zhou S, Nao J.

Ageing Res Rev. 2023 Jun;87:101910. doi: 10.1016/j.arr.2023.101910. Epub 2023 Mar 15.

Re-remembering the influence of randomized β-carotene on cognitive decline

Kopec RE, Chasman DI, Okereke OI, Sesso HD.

Alzheimers Dement. 2023 Aug;19(8):3718-3721. doi: 10.1002/alz.13018. Epub 2023 Mar 20.

New insights toward molecular and nanotechnological approaches to antidiabetic agents for Alzheimer's disease

Pradhan SP, Sahu PK, Behera A.

Mol Cell Biochem. 2023 Dec;478(12):2739-2762. doi: 10.1007/s11010-023-04696-1. Epub 2023 Mar 22.

Insulin-like growth factor-2 is a promising candidate for the treatment and prevention of Alzheimer's disease

Fitzgerald GS, Chuchta TG, McNay EC.

CNS Neurosci Ther. 2023 Jun;29(6):1449-1469. doi: 10.1111/cns.14160. Epub 2023 Mar 27.

New Pathways Identify Novel Drug Targets for the Prevention and Treatment of Alzheimer's Disease

Penke B, Szűcs M, Bogár F.

Int J Mol Sci. 2023 Mar 11;24(6):5383. doi: 10.3390/ijms24065383.

Cardiovascular Risk Management in Persons with Dementia

Nijskens C, Henstra M, Rhodius-Meester H, Yasar S, van Poelgeest E, Peters M, Muller M.

J Alzheimers Dis. 2023;93(3):879-889. doi: 10.3233/JAD-230019.

Cytosolic calcium: Judge, jury and executioner of neurodegeneration in Alzheimer's disease and beyond

Webber EK, Fivaz M, Stutzmann GE, Griffioen G.

Alzheimers Dement. 2023 Aug;19(8):3701-3717. doi: 10.1002/alz.13065. Epub 2023 May 3.

Clinical Effect of Early vs Late Amyloid Positron Emission Tomography in Memory Clinic Patients: The AMYPAD-DPMS Randomized Clinical Trial

Altomare D, Barkhof F, Caprioglio C, Collij LE, Scheltens P, Lopes Alves I, Bouwman F, Berkhof J, van Maurik IS, Garibotto V, Moro C, Delrieu J, Payoux P, Saint-Aubert L, Hitzel A, Molinuevo JL, Grau-Rivera O, Gispert JD, Drzezga A, Jessen F, Zeyen P, Nordberg A, Savitcheva I, Jelic V, Walker Z, Edison P, Demonet JF, Gismondi R, Farrar G, Stephens AW, Frisoni GB; Amyloid Imaging to Prevent Alzheimer’s Disease (AMYPAD) Consortium.

JAMA Neurol. 2023 Jun 1;80(6):548-557. doi: 10.1001/jamaneurol.2023.0997.

An updated overview of recent and ongoing deep brain stimulation (DBS) trials in patients with dementia: a systematic review

Remoli G, Tariciotti L, Remore LG, Palmisciano P, Sciancalepore F, Canevelli M, Lacorte E, Da Re F, Bruno G, Ferrarese C, Appollonio I, Locatelli M, Vanacore N.

Neurol Sci. 2023 Oct;44(10):3395-3427. doi: 10.1007/s10072-023-06821-w. Epub 2023 May 19.

The Effects of Medium Chain Triglyceride for Alzheimer's Disease Related Cognitive Impairment: A Systematic Review and Meta-Analysis

Sun L, Ye KX, Wong HLK, Wang L, Lim SL, Chao YX, Zhang C, Yap KZ, Feng L.

J Alzheimers Dis. 2023;94(2):441-456. doi: 10.3233/JAD-230406.

Turning the Spotlight to Cholinergic Pharmacotherapy of the Human Language System

Dávila G, Torres-Prioris MJ, López-Barroso D, Berthier ML.

CNS Drugs. 2023 Jul;37(7):599-637. doi: 10.1007/s40263-023-01017-4. Epub 2023 Jun 21.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias